PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1980 | 3 |
| 1983 | 1 |
| 1984 | 1 |
| 1992 | 2 |
| 1997 | 1 |
| 1998 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 3 |
| 2005 | 9 |
| 2006 | 11 |
| 2007 | 22 |
| 2008 | 111 |
| 2009 | 95 |
| 2010 | 105 |
| 2011 | 91 |
| 2012 | 142 |
| 2013 | 94 |
| 2014 | 101 |
| 2015 | 92 |
| 2016 | 104 |
| 2017 | 64 |
| 2018 | 31 |
| 2019 | 65 |
| 2020 | 65 |
| 2021 | 51 |
| 2022 | 63 |
| 2023 | 59 |
| 2024 | 70 |
| 2025 | 55 |
| 2026 | 22 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Urol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Delineating the Long-Term Incidence of Urethral Complications After Prostate Cancer Treatment: A Population-Based Analysis.
- Calvo CI, Rourke KF.
- J Urol. 2026 Aug 7;216(5):654-662. doi: 10.1097/JU.0000000000005222.
- PMCID: PMC13657388
Calvo CI, et al.J Urol. 2026.PMCID: PMC13657388 -
Durable Responses and Cystectomy Avoidance With Interleukin-15 Receptor Agonist NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer With Carcinoma In Situ ± Papillary Disease.
- Chang SS, Chamie K, Seabury CA, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS, Trabulsi EJ, Trainer AF, Spilman P, Drusbosky LM, Brown B, Huang M, Bhar P, Sender L, Reddy S, Soon-Shiong P.
- J Urol. 2026 Jul 6;216(5):663-675. doi: 10.1097/JU.0000000000005198.
- PMCID: PMC13657391
Chang SS, et al.J Urol. 2026.PMCID: PMC13657391 -
Age and Postoperative Unplanned Reintubation: A Retrospective Observational Study Using the NSQIP Pediatric Database.
- Michael J, Wu C, Rosoklija I, Johnson EK, Burjek N, Lazar A, Froyshteter AB, Cheon EC, Chu DI.
- J Urol. Author manuscript. 2026 Jun 18;216(4):579-588. doi: 10.1097/JU.0000000000005177.
- PMCID: PMC13653598
Michael J, et al.J Urol. Author manuscript. 2026.PMCID: PMC13653598 -
Diagnostic Test Characteristics of Renal Ultrasound Findings for High-Risk Bladder in Spina Bifida.
- Morgantini LA, Herrera D, Hirsch J, Meyer T, Huang LW, Rosoklija I, Bowen DK, Cheng EY, Yerkes EB, Chu DI.
- J Urol. Author manuscript. 2026 Jul 17;216(5):724-731. doi: 10.1097/JU.0000000000005223.
- PMCID: PMC13652668
Morgantini LA, et al.J Urol. Author manuscript. 2026.PMCID: PMC13652668 -
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.
- Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, Brown GA, Chen R, Lin D, Witte J, Cooperberg MR, Catalona WJ, Gross CP, Ma X.
- J Urol. Author manuscript. 2023 Feb 8;209(4):710-718. doi: 10.1097/JU.0000000000003159.
- PMCID: PMC13616421
Leapman MS, et al.J Urol. Author manuscript. 2023.PMCID: PMC13616421 -
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
- Lawen T, Garcia RS, Smith MT, Pyo J, Higgason NM, Robert MJM, Chapin BF, Chery LS, Davis JW, Ward JF, Pisters LL, Pettaway CA, Hahn AW, Frigo DE, Wei P, Daniel CR, Gregg JR.
- J Urol. Author manuscript. 2026 Feb 9;215(6):679-687. doi: 10.1097/JU.0000000000004986.
- PMCID: PMC13580391
Lawen T, et al.J Urol. Author manuscript. 2026.PMCID: PMC13580391 -
With Great Cost Comes Great Responsibility: Who Will Own the Rising Costs of Bladder Cancer Care?
- Joyce DD, Sharma V, Boorjian SA.
- J Urol. Author manuscript. 2026 Jun 26;216(4):487-489. doi: 10.1097/JU.0000000000005185.
- PMCID: PMC13575758
Joyce DD, et al.J Urol. Author manuscript. 2026.PMCID: PMC13575758 -
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.
- George A, Giesler E, Mazzarella B, Levin R, Frendl D, Warlick C, Given R, Kella N, Frye T, Mynderse L, Kasraeian A, Milbank A, Nabbout P, Grunberger I, Rastinehad A, Schwartz M, Wysock J, Rousseau M, Pliskin M, Satkunasivam R, Rich D, Shore ND, Moreno J, Belkoff L, Sidana A, Taneja SS.
- J Urol. 2026 Jun 10;216(4):527-539. doi: 10.1097/JU.0000000000005156.
- PMCID: PMC13561094
George A, et al.J Urol. 2026.PMCID: PMC13561094 -
Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy Plus Bacillus Calmette-Guérin for High-Risk Nonmuscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN.
- Joyce DD, Sharma V, Ratcliff GE, Barocas DA, Chang SS, Penson DF, Packiam VT, Kulkarni G, Wymer KM, Boorjian SA.
- J Urol. Author manuscript. 2026 May 18;216(3):400-411. doi: 10.1097/JU.0000000000005126.
- PMCID: PMC13541237
Joyce DD, et al.J Urol. Author manuscript. 2026.PMCID: PMC13541237 -
Frailty Is Associated With Postoperative Complications and Device Removal and Revision in Men Undergoing Surgery for Stress Urinary Incontinence.
- Nik-Ahd F, Dreyfuss LD, Wang L, Shatkin-Margolis A, Boscardin WJ, Hampson LA, Breyer BN, Covinsky K, Suskind AM.
- J Urol. Author manuscript. 2026 Jul 15;216(3):433-441. doi: 10.1097/JU.0000000000005102.
- PMCID: PMC13505961
Nik-Ahd F, et al.J Urol. Author manuscript. 2026.PMCID: PMC13505961